Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | Patent Number 10195214

US 10195214 B2
Application Number15627359
Publication NumberUS 20170326157 A1
Pendency1 year, 7 months, 21 days
Filled DateJun 19, 2017
Priority DateMar 1, 2017
Publication DateNov 16, 2017
Expiration DateFeb 28, 2037
Inventor/ApplicantsJoseph K. Belanoff
ExaminesSIMMONS, CHRIS E
Art Unit1629
Technology Center1600
Assignments
Corcept Therapeutics
Current
Corcept Therapeutics
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.